Dr Muzvare Betty Makoni Twitterissä: "@zenisiwe Rinobva mbichana mbichana. Haribve zvekumhanya aiwa. Ndinaro but mbichana haro. Every minute unobuditsa mbichana mbichana. Pese apa ndanga ndisingakwanise kukosora. Madoctors ekuno now gararwa Saka vari
![Dr Muzvare Betty Makoni on Twitter: "@Tarisai_Moyo Ndakapihwa aya maantibiotic aya. Ndakatangwa highest dose re200mg. Pandakamwa ndakanzwa kuti zvedi enemy has met their match. Within a day ndakatanga kubuda gararwa. But antibiotic Dr Muzvare Betty Makoni on Twitter: "@Tarisai_Moyo Ndakapihwa aya maantibiotic aya. Ndakatangwa highest dose re200mg. Pandakamwa ndakanzwa kuti zvedi enemy has met their match. Within a day ndakatanga kubuda gararwa. But antibiotic](https://pbs.twimg.com/media/EUQorjxXQAAQvSr.jpg)
Dr Muzvare Betty Makoni on Twitter: "@Tarisai_Moyo Ndakapihwa aya maantibiotic aya. Ndakatangwa highest dose re200mg. Pandakamwa ndakanzwa kuti zvedi enemy has met their match. Within a day ndakatanga kubuda gararwa. But antibiotic
![Added by @annaieremie Instagram post And keep going 🙄 #fluseason #tablets # doxycycline #hatethis 🙀😥 - Picuki.com Added by @annaieremie Instagram post And keep going 🙄 #fluseason #tablets # doxycycline #hatethis 🙀😥 - Picuki.com](https://scontent-lga3-1.cdninstagram.com/v/t51.2885-15/e35/79813070_163094938287634_8030700330510988066_n.jpg?_nc_ht=scontent-lga3-1.cdninstagram.com&_nc_cat=110&_nc_ohc=t2TvjvN0gZIAX8hEM1F&oh=1f43fc125a48f18e88f8edb72eedc089&oe=5EB8B2DE)
Added by @annaieremie Instagram post And keep going 🙄 #fluseason #tablets # doxycycline #hatethis 🙀😥 - Picuki.com
![Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet Respiratory Medicine Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/53756309-7055-44ad-93e8-367dbd47aa72/gr1.jpg)